Center for Cardiometabolic Science, Christina Lee Brown Envirome Institute, Division of Environmental Medicine, Department of Medicine, Delia B. Baxter Research Building, University of Louisville, 580 S. Preston S, Louisville, KY 40202, USA.
Redox Biol. 2023 Jul;63:102747. doi: 10.1016/j.redox.2023.102747. Epub 2023 May 16.
For years, females were thought of as smaller men with complex hormonal cycles; as a result, females have been largely excluded from preclinical and clinical research. However, in the last ten years, with the increased focus on sex as a biological variable, it has become clear that this is not the case, and in fact, male and female cardiovascular biology and cardiac stress responses differ substantially. Premenopausal women are protected from cardiovascular diseases, such as myocardial infarction and resultant heart failure, having preserved cardiac function, reduced adverse remodeling, and increased survival. Many underlying biological processes that contribute to ventricular remodeling differ between the sexes, such as cellular metabolism; immune cell responses; cardiac fibrosis and extracellular matrix remodeling; cardiomyocyte dysfunction; and endothelial biology; however, it is unclear how these changes afford protection to the female heart. Although many of these changes are dependent on protection provided by female sex hormones, several of these changes occur independent of sex hormones, suggesting that the nature of these changes is more complex than initially thought. This may be why studies focused on the cardiovascular benefits of hormone replacement therapy in post-menopausal women have provided mixed results. Some of the complexity likely stems from the fact that the cellular composition of the heart is sexually dimorphic and that in the setting of MI, different subpopulations of these cell types are apparent. Despite the documented sex-differences in cardiovascular (patho)physiology, the underlying mechanisms that contribute are largely unknown due to inconsistent findings amongst investigators and, in some cases, lack of rigor in reporting and consideration of sex-dependent variables. Therefore, this review aims to describe current understanding of the sex-dependent differences in the myocardium in response to physiological and pathological stressors, with a focus on the sex-dependent differences that contribute to post-infarction remodeling and resultant functional decline.
多年来,人们一直认为女性是男性的缩小版,具有复杂的激素周期;因此,女性在很大程度上被排除在临床前和临床研究之外。然而,在过去的十年中,随着人们对性作为生物学变量的关注度增加,很明显情况并非如此,事实上,男性和女性的心血管生物学和心脏应激反应有很大的不同。绝经前女性受到保护,免受心血管疾病的影响,如心肌梗死和由此导致的心力衰竭,具有保留的心脏功能、减少不良重构和增加存活率。导致心室重构的许多潜在生物学过程在性别之间存在差异,例如细胞代谢;免疫细胞反应;心脏纤维化和细胞外基质重构;心肌细胞功能障碍;和内皮生物学;然而,这些变化如何为女性心脏提供保护尚不清楚。尽管这些变化中的许多依赖于女性性激素提供的保护,但其中一些变化独立于性激素发生,这表明这些变化的性质比最初想象的要复杂。这可能就是为什么专注于绝经后女性激素替代疗法对心血管益处的研究提供了混合结果的原因。这种复杂性的一部分可能源于心脏的细胞组成存在性别二态性,并且在 MI 情况下,这些细胞类型的不同亚群是明显的。尽管有文件证明心血管(病理)生理学存在性别差异,但由于研究人员之间的发现不一致,并且在某些情况下,缺乏对性别相关变量的严格报告和考虑,导致导致这些差异的潜在机制在很大程度上仍不清楚。因此,本综述旨在描述目前对心肌对生理和病理应激的性别依赖性差异的理解,重点是导致梗死后重构和功能下降的性别依赖性差异。